Q:
Is the viability of cells from diseased or diabetic donors less than cells from normal donors?
A:
We guarantee > 70 % viability for cells from both diseased/diabetic donors and normal donors.
Categories:
Primary Cells and Media
Research Areas:
Cancer Research/Cell Biology
Cardiovascular
Dermatology/Tissue Engineering
Gastroenterology
Immunotherapy / Hematology
Stem Cells
Basic Research
Toxicology
You may also want to know:
How many donors are pooled to create the pooled human cells?
What is the difference between each of the types of HUVECs that Lonza offers?
Are Lonza’s melanocytes classified/categorized by the donor’s skin tone?
How old are the donors for Lonza’s dermal cells from neonatal donors?
What donor characteristics are available for the diseased airway cells?
Do we know the severity of the asthma or the genotype of the cystic fibrosis donors?
Can customers buy PBMCs from COVID-19 infected donors?
What additional donor information is available for Lonza’s diseased airway cells?
Are the Clonetics™ embryonic rat/mouse neuronal cells from a single donor or pooled?
Are the Rat Aortic Smooth Muscle Cells R-ASM-580 derived from single donor or does each lot contain a pool from several animals?
See More